Global and China Biologics Market Insights, Forecast to 2027

Publisher Name :
Date: 30-Sep-2021
No. of pages: 147
Inquire Before Buying

Biologics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Biologics market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Monoclonal Antibodies

- Vaccines

- Recombinant Proteins

- Antisense

- RNAi

Segment by Application

- Infectious Diseases

- Oncology

- Immunology

- Autoimmune Diseases

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Eli Lilly & Company

- Samsung Biologics

- F Hoffman La Roche

- Celltrion

- Addgene

- Amgen

- Abbvie Inc.

- Sanofi

- Pfizer Inc.

- Merck & Co. Inc.

- Novo Nordisk A/S

- Johnson & Johnson Services Inc.

Global and China Biologics Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Biologics Market Size Growth Rate by Type
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Recombinant Proteins
1.2.5 Antisense
1.2.6 RNAi
1.3 Market by Application
1.3.1 Global Biologics Market Size Growth Rate by Application
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Immunology
1.3.5 Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologics Market Size, Estimates and Forecasts
2.1.1 Global Biologics Revenue 2016-2027
2.1.2 Global Biologics Sales 2016-2027
2.2 Global Biologics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Biologics Historical Market Size by Region (2016-2021)
2.3.1 Global Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Biologics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biologics Sales Forecast by Region (2022-2027)
2.4.2 Global Biologics Revenue Forecast by Region (2022-2027)
3 Global Biologics Competitor Landscape by Players
3.1 Global Top Biologics Manufacturers by Sales
3.1.1 Global Biologics Sales by Manufacturer (2016-2021)
3.1.2 Global Biologics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biologics Manufacturers by Revenue
3.2.1 Key Biologics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Biologics Revenue by Manufacturers (2016-2021)
3.2.3 Global Biologics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Biologics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Biologics Revenue in 2020
3.2.6 Global Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biologics Price by Manufacturers
3.4 Global Biologics Manufacturing Base Distribution, Product Types
3.4.1 Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Biologics Market Size by Type (2016-2021)
4.1.1 Global Biologics Sales by Type (2016-2021)
4.1.2 Global Biologics Revenue by Type (2016-2021)
4.1.3 Biologics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Biologics Market Size Forecast by Type (2022-2027)
4.2.1 Global Biologics Sales Forecast by Type (2022-2027)
4.2.2 Global Biologics Revenue Forecast by Type (2022-2027)
4.2.3 Biologics Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Biologics Market Size by Application (2016-2021)
5.1.1 Global Biologics Sales by Application (2016-2021)
5.1.2 Global Biologics Revenue by Application (2016-2021)
5.1.3 Biologics Price by Application (2016-2021)
5.2 Biologics Market Size Forecast by Application (2022-2027)
5.2.1 Global Biologics Sales Forecast by Application (2022-2027)
5.2.2 Global Biologics Revenue Forecast by Application (2022-2027)
5.2.3 Global Biologics Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Biologics Market Size YoY Growth 2016-2027
6.1.1 China Biologics Sales YoY Growth 2016-2027
6.1.2 China Biologics Revenue YoY Growth 2016-2027
6.1.3 China Biologics Market Share in Global Market 2016-2027
6.2 China Biologics Market Size by Players (International and Local Players)
6.2.1 China Top Biologics Players by Sales (2016-2021)
6.2.2 China Top Biologics Players by Revenue (2016-2021)
6.3 China Biologics Historic Market Review by Type (2016-2021)
6.3.1 China Biologics Sales Market Share by Type (2016-2021)
6.3.2 China Biologics Revenue Market Share by Type (2016-2021)
6.3.3 China Biologics Price by Type (2016-2021)
6.4 China Biologics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Biologics Sales Forecast by Type (2022-2027)
6.4.2 China Biologics Revenue Forecast by Type (2022-2027)
6.4.3 China Biologics Price Forecast by Type (2022-2027)
6.5 China Biologics Historic Market Review by Application (2016-2021)
6.5.1 China Biologics Sales Market Share by Application (2016-2021)
6.5.2 China Biologics Revenue Market Share by Application (2016-2021)
6.5.3 China Biologics Price by Application (2016-2021)
6.6 China Biologics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Biologics Sales Forecast by Application (2022-2027)
6.6.2 China Biologics Revenue Forecast by Application (2022-2027)
6.6.3 China Biologics Price Forecast by Application (2022-2027)
7 North America
7.1 North America Biologics Market Size YoY Growth 2016-2027
7.2 North America Biologics Market Facts & Figures by Country
7.2.1 North America Biologics Sales by Country (2016-2021)
7.2.2 North America Biologics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Biologics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Biologics Market Facts & Figures by Region
8.2.1 Asia Pacific Biologics Sales by Region (2016-2021)
8.2.2 Asia Pacific Biologics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Biologics Market Size YoY Growth 2016-2027
9.2 Europe Biologics Market Facts & Figures by Country
9.2.1 Europe Biologics Sales by Country (2016-2021)
9.2.2 Europe Biologics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Biologics Market Size YoY Growth 2016-2027
10.2 Latin America Biologics Market Facts & Figures by Country
10.2.1 Latin America Biologics Sales by Country (2016-2021)
10.2.2 Latin America Biologics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biologics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biologics Market Facts & Figures by Country
11.2.1 Middle East and Africa Biologics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Biologics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Eli Lilly & Company
12.1.1 Eli Lilly & Company Corporation Information
12.1.2 Eli Lilly & Company Description and Business Overview
12.1.3 Eli Lilly & Company Biologics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Eli Lilly & Company Biologics Products Offered
12.1.5 Eli Lilly & Company Recent Development
12.2 Samsung Biologics
12.2.1 Samsung Biologics Corporation Information
12.2.2 Samsung Biologics Description and Business Overview
12.2.3 Samsung Biologics Biologics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Samsung Biologics Biologics Products Offered
12.2.5 Samsung Biologics Recent Development
12.3 F Hoffman La Roche
12.3.1 F Hoffman La Roche Corporation Information
12.3.2 F Hoffman La Roche Description and Business Overview
12.3.3 F Hoffman La Roche Biologics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 F Hoffman La Roche Biologics Products Offered
12.3.5 F Hoffman La Roche Recent Development
12.4 Celltrion
12.4.1 Celltrion Corporation Information
12.4.2 Celltrion Description and Business Overview
12.4.3 Celltrion Biologics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Celltrion Biologics Products Offered
12.4.5 Celltrion Recent Development
12.5 Addgene
12.5.1 Addgene Corporation Information
12.5.2 Addgene Description and Business Overview
12.5.3 Addgene Biologics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Addgene Biologics Products Offered
12.5.5 Addgene Recent Development
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Description and Business Overview
12.6.3 Amgen Biologics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amgen Biologics Products Offered
12.6.5 Amgen Recent Development
12.7 Abbvie Inc.
12.7.1 Abbvie Inc. Corporation Information
12.7.2 Abbvie Inc. Description and Business Overview
12.7.3 Abbvie Inc. Biologics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbvie Inc. Biologics Products Offered
12.7.5 Abbvie Inc. Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Description and Business Overview
12.8.3 Sanofi Biologics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Biologics Products Offered
12.8.5 Sanofi Recent Development
12.9 Pfizer Inc.
12.9.1 Pfizer Inc. Corporation Information
12.9.2 Pfizer Inc. Description and Business Overview
12.9.3 Pfizer Inc. Biologics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pfizer Inc. Biologics Products Offered
12.9.5 Pfizer Inc. Recent Development
12.10 Merck & Co. Inc.
12.10.1 Merck & Co. Inc. Corporation Information
12.10.2 Merck & Co. Inc. Description and Business Overview
12.10.3 Merck & Co. Inc. Biologics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck & Co. Inc. Biologics Products Offered
12.10.5 Merck & Co. Inc. Recent Development
12.11 Eli Lilly & Company
12.11.1 Eli Lilly & Company Corporation Information
12.11.2 Eli Lilly & Company Description and Business Overview
12.11.3 Eli Lilly & Company Biologics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Eli Lilly & Company Biologics Products Offered
12.11.5 Eli Lilly & Company Recent Development
12.12 Johnson & Johnson Services Inc.
12.12.1 Johnson & Johnson Services Inc. Corporation Information
12.12.2 Johnson & Johnson Services Inc. Description and Business Overview
12.12.3 Johnson & Johnson Services Inc. Biologics Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Johnson & Johnson Services Inc. Products Offered
12.12.5 Johnson & Johnson Services Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Biologics Industry Trends
13.2 Biologics Market Drivers
13.3 Biologics Market Challenges
13.4 Biologics Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Biologics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Vaccines
Table 4. Major Manufacturers of Recombinant Proteins
Table 5. Major Manufacturers of Antisense
Table 6. Major Manufacturers of RNAi
Table 7. Global Biologics Market Size Growth Rate by Application (2021-2027) & (MT)
Table 8. Global Biologics Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Biologics Sales by Regions (2016-2021) & (MT)
Table 10. Global Biologics Sales Market Share by Regions (2016-2021)
Table 11. Global Biologics Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Biologics Sales Forecast by Region (2022-2027) & (MT)
Table 13. Global Biologics Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Biologics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Biologics Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Biologics Sales by Manufacturers (2016-2021) (MT)
Table 17. Global Biologics Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Biologics Manufacturers by Revenue (US$ Million) in 2020
Table 19. Biologics Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Biologics Revenue Share by Manufacturers (2016-2021)
Table 21. Global Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics as of 2020)
Table 23. Key Manufacturers Biologics Price (2016-2021) (USD/MT)
Table 24. Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Biologics Product Type
Table 26. Date of International Manufacturers Enter into Biologics Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Biologics Sales by Type (2016-2021) (MT)
Table 29. Global Biologics Sales Share by Type (2016-2021)
Table 30. Global Biologics Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Biologics Revenue Share by Type (2016-2021)
Table 32. Biologics Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 33. Global Biologics Sales Forecast by Type (2022-2027) & (MT)
Table 34. Global Biologics Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Biologics Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Biologics Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Biologics Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 38. Global Biologics Sales by Application (2016-2021) (MT)
Table 39. Global Biologics Sales Share by Application (2016-2021)
Table 40. Global Biologics Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Biologics Revenue Share by Application (2016-2021)
Table 42. Biologics Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 43. Global Biologics Sales Forecast by Application (2022-2027) & (MT)
Table 44. Global Biologics Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Biologics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Biologics Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Biologics Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 48. China Biologics Sales (MT) of Key Companies (2016-2021)
Table 49. China Biologics Sales Share by Company (2016-2021)
Table 50. China Biologics Revenue (US$ Million) by Company (2016-2021)
Table 51. China Biologics Revenue Share by Company (2016-2021)
Table 52. China Biologics Sales (MT) by Type (2016-2021)
Table 53. China Biologics Sales Share by Type (2016-2021)
Table 54. China Biologics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Biologics Price (USD/MT) by Type (2016-2021)
Table 56. China Biologics Sales (MT) by Type (2022-2027)
Table 57. China Biologics Sales Share by Type (2022-2027)
Table 58. China Biologics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Biologics Revenue Share by Type (2022-2027)
Table 60. China Biologics Price (USD/MT) by Type (2022-2027)
Table 61. China Biologics Sales (MT) by Application (2016-2021)
Table 62. China Biologics Sales Share by Application (2016-2021)
Table 63. China Biologics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Biologics Price (USD/MT) by Application (2016-2021)
Table 65. China Biologics Sales (MT) by Application (2022-2027)
Table 66. China Biologics Sales Share by Application (2022-2027)
Table 67. China Biologics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Biologics Revenue Share by Application (2022-2027)
Table 69. China Biologics Price (USD/MT) by Application (2022-2027)
Table 70. North America Biologics Sales by Country (2016-2021) & (MT)
Table 71. North America Biologics Sales Market Share by Country (2016-2021)
Table 72. North America Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Biologics Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Biologics Sales by Region (2016-2021) & (MT)
Table 75. Asia Pacific Biologics Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Biologics Revenue Market Share by Region (2016-2021)
Table 78. Europe Biologics Sales by Country (2016-2021) & (MT)
Table 79. Europe Biologics Sales Market Share by Country (2016-2021)
Table 80. Europe Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Biologics Revenue Market Share by Country (2016-2021)
Table 82. Latin America Biologics Sales by Country (2016-2021) & (MT)
Table 83. Latin America Biologics Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Biologics Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Biologics Sales by Country (2016-2021) & (MT)
Table 87. Middle East and Africa Biologics Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Biologics Revenue Market Share by Country (2016-2021)
Table 90. Eli Lilly & Company Corporation Information
Table 91. Eli Lilly & Company Description and Business Overview
Table 92. Eli Lilly & Company Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 93. Eli Lilly & Company Biologics Product
Table 94. Eli Lilly & Company Recent Development
Table 95. Samsung Biologics Corporation Information
Table 96. Samsung Biologics Description and Business Overview
Table 97. Samsung Biologics Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 98. Samsung Biologics Product
Table 99. Samsung Biologics Recent Development
Table 100. F Hoffman La Roche Corporation Information
Table 101. F Hoffman La Roche Description and Business Overview
Table 102. F Hoffman La Roche Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 103. F Hoffman La Roche Product
Table 104. F Hoffman La Roche Recent Development
Table 105. Celltrion Corporation Information
Table 106. Celltrion Description and Business Overview
Table 107. Celltrion Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 108. Celltrion Product
Table 109. Celltrion Recent Development
Table 110. Addgene Corporation Information
Table 111. Addgene Description and Business Overview
Table 112. Addgene Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Addgene Product
Table 114. Addgene Recent Development
Table 115. Amgen Corporation Information
Table 116. Amgen Description and Business Overview
Table 117. Amgen Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Amgen Product
Table 119. Amgen Recent Development
Table 120. Abbvie Inc. Corporation Information
Table 121. Abbvie Inc. Description and Business Overview
Table 122. Abbvie Inc. Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Abbvie Inc. Product
Table 124. Abbvie Inc. Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Sanofi Product
Table 129. Sanofi Recent Development
Table 130. Pfizer Inc. Corporation Information
Table 131. Pfizer Inc. Description and Business Overview
Table 132. Pfizer Inc. Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Pfizer Inc. Product
Table 134. Pfizer Inc. Recent Development
Table 135. Merck & Co. Inc. Corporation Information
Table 136. Merck & Co. Inc. Description and Business Overview
Table 137. Merck & Co. Inc. Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Merck & Co. Inc. Product
Table 139. Merck & Co. Inc. Recent Development
Table 140. Novo Nordisk A/S Corporation Information
Table 141. Novo Nordisk A/S Description and Business Overview
Table 142. Novo Nordisk A/S Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Novo Nordisk A/S Product
Table 144. Novo Nordisk A/S Recent Development
Table 145. Johnson & Johnson Services Inc. Corporation Information
Table 146. Johnson & Johnson Services Inc. Description and Business Overview
Table 147. Johnson & Johnson Services Inc. Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 148. Johnson & Johnson Services Inc. Product
Table 149. Johnson & Johnson Services Inc. Recent Development
Table 150. Biologics Market Trends
Table 151. Biologics Market Drivers
Table 152. Biologics Market Challenges
Table 153. Biologics Market Restraints
Table 154. Biologics Customers List
Table 155. Biologics Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Product Picture
Figure 2. Global Biologics Sales Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Recombinant Proteins Product Picture
Figure 6. Antisense Product Picture
Figure 7. RNAi Product Picture
Figure 8. Global Biologics Sales Market Share by Application in 2020 & 2027
Figure 9. Infectious Diseases
Figure 10. Oncology
Figure 11. Immunology
Figure 12. Autoimmune Diseases
Figure 13. Biologics Report Years Considered
Figure 14. Global Biologics Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Biologics Market Size 2016-2027 (US$ Million)
Figure 16. Global Biologics Sales 2016-2027 (MT)
Figure 17. Global Biologics Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Biologics Sales Market Share by Region (2016-2021)
Figure 19. Global Biologics Sales Market Share by Region in 2020
Figure 20. Global Biologics Revenue Market Share by Region (2016-2021)
Figure 21. Global Biologics Revenue Market Share by Region in 2020
Figure 22. Global Biologics Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Biologics Revenue in 2020
Figure 24. Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Biologics Sales Market Share by Type (2016-2021)
Figure 26. Global Biologics Sales Market Share by Type in 2020
Figure 27. Global Biologics Revenue Market Share by Type (2016-2021)
Figure 28. Global Biologics Revenue Market Share by Type in 2020
Figure 29. Global Biologics Sales Market Share by Application (2016-2021)
Figure 30. Global Biologics Sales Market Share by Application in 2020
Figure 31. Global Biologics Revenue Market Share by Application (2016-2021)
Figure 32. Global Biologics Revenue Market Share by Application in 2020
Figure 33. China Biologics Sales Growth Rate 2016-2027 (MT)
Figure 34. China Biologics Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Biologics Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Biologics Players Market Share by Revenue in Biologics in 2020
Figure 37. China Biologics Revenue Share by Type (2016-2021)
Figure 38. China Biologics Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Biologics Revenue Share by Application (2016-2021)
Figure 40. China Biologics Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Biologics Sales Growth Rate 2016-2021 (MT)
Figure 42. North America Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Biologics Sales Market Share by Country in 2020
Figure 44. North America Biologics Revenue Market Share by Country in 2020
Figure 45. U.S. Biologics Sales Growth Rate (2016-2021) (MT)
Figure 46. U.S. Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Biologics Sales Growth Rate (2016-2021) (MT)
Figure 48. Canada Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Biologics Sales Growth Rate 2016-2021 (MT)
Figure 50. Europe Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Biologics Sales Market Share by Country in 2020
Figure 52. Europe Biologics Revenue Market Share by Country in 2020
Figure 53. Germany Biologics Sales Growth Rate (2016-2021) (MT)
Figure 54. Germany Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Biologics Sales Growth Rate (2016-2021) (MT)
Figure 56. France Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Biologics Sales Growth Rate (2016-2021) (MT)
Figure 58. U.K. Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Biologics Sales Growth Rate (2016-2021) (MT)
Figure 60. Italy Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Biologics Sales Growth Rate (2016-2021) (MT)
Figure 62. Russia Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Biologics Sales Growth Rate 2016-2021 (MT)
Figure 64. Asia Pacific Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Biologics Sales Market Share by Region in 2020
Figure 66. Asia Pacific Biologics Revenue Market Share by Region in 2020
Figure 67. China Biologics Sales Growth Rate (2016-2021) (MT)
Figure 68. China Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Biologics Sales Growth Rate (2016-2021) (MT)
Figure 70. Japan Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Biologics Sales Growth Rate (2016-2021) (MT)
Figure 72. South Korea Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Biologics Sales Growth Rate (2016-2021) (MT)
Figure 74. India Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Biologics Sales Growth Rate (2016-2021) (MT)
Figure 76. Australia Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Biologics Sales Growth Rate (2016-2021) (MT)
Figure 78. Taiwan Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Biologics Sales Growth Rate (2016-2021) (MT)
Figure 80. Indonesia Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Biologics Sales Growth Rate (2016-2021) (MT)
Figure 82. Thailand Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Biologics Sales Growth Rate (2016-2021) (MT)
Figure 84. Malaysia Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Biologics Sales Growth Rate (2016-2021) (MT)
Figure 86. Philippines Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Biologics Sales Growth Rate (2016-2021) (MT)
Figure 88. Vietnam Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Biologics Sales Growth Rate 2016-2021 (MT)
Figure 90. Latin America Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Biologics Sales Market Share by Country in 2020
Figure 92. Latin America Biologics Revenue Market Share by Country in 2020
Figure 93. Mexico Biologics Sales Growth Rate (2016-2021) (MT)
Figure 94. Mexico Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Biologics Sales Growth Rate (2016-2021) (MT)
Figure 96. Brazil Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Biologics Sales Growth Rate (2016-2021) (MT)
Figure 98. Argentina Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Biologics Sales Growth Rate 2016-2021 (MT)
Figure 100. Middle East and Africa Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Biologics Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Biologics Revenue Market Share by Country in 2020
Figure 103. Turkey Biologics Sales Growth Rate (2016-2021) (MT)
Figure 104. Turkey Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Biologics Sales Growth Rate (2016-2021) (MT)
Figure 106. Saudi Arabia Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. U.A.E Biologics Sales Growth Rate (2016-2021) (MT)
Figure 108. U.A.E Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Biologics Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
  • Global Nucleotide Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 132
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Nucleotide Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 165
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Bioburden Testing Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: The Global Bioburden Testing Market Size was estimated at USD 898.90 million in 2022 and is projected to reach USD 1443.44 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Bioburden Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market dri......
  • Global qPCR Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global qPCR market: According to our latest research, the global qPCR market looks promising in the next 5 years. As of 2022, the global qPCR market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global qPCR market, with a systematical description of the status ......
  • Global Interferon Market Research Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Interferon Professional Survey Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 3280 Onwards        Pages: 107
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Biologics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Biologics market: According to our latest research, the global Biologics market looks promising in the next 5 years. As of 2022, the global Biologics market was estimated at USD 251622.83 million, and it's anticipated to reach USD 363588.32 million in 2028, with a CAGR of 6.33% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biologics market, with a sys......
  • Global Nucleotide Market Insights, Forecast to 2029
    Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 89
    Nucleotides are small organic molecules composed of purine bases or pyrimidine bases, pentoses and phosphoric acid. They are the structural units of nucleic acids, and their derivatives have a variety of biological functions. It can be used in the fields of food, pharmaceuticals and feed additive. The global Nucleotide market is projected to grow from US$ 511.1 million in 2023 to US$ 492.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.6% during the forecast period. ......
  • 2023-2031 Report on Global Nucleotide Market by Player, Region, Type, Application and Sales Channel
    Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Nucleotide market, covering market size for segment by type (Food Grade Nucleotide, Lab Grade Nucleotide, etc.), by application (Pharmaceuticals, Food & Beverage Additives, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AJINOMOTO, CJ, DAESANG, Meihua Group, Star Lake Bioscience, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs